share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Officer Sperzel John J III

SEC announcement ·  Feb 28 05:36
Summary by Futu AI
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 24, 2024, involving the acquisition of 67 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have reached a total of 400 shares. The transaction price and total value of the shares were not disclosed in the announcement.
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 24, 2024, involving the acquisition of 67 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have reached a total of 400 shares. The transaction price and total value of the shares were not disclosed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.